112 related articles for article (PubMed ID: 23790177)
1. Radioiodine therapy accelerates apoptosis in peripheral blood lymphocytes of patients with differentiated thyroid cancer.
Vrndic O; Milosevic-Djordjevic O; Djurdjevic P; Jovanovic D; Mijatovic L; Jeftic I; Simonovic SZ
Neoplasma; 2013; 60(5):568-75. PubMed ID: 23790177
[TBL] [Abstract][Full Text] [Related]
2. Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis.
Joseph LJ; Bhartiya US; Raut YS; Kand P; Hawaldar RW; Nair N
Mutat Res; 2009 Apr; 675(1-2):35-40. PubMed ID: 19386245
[TBL] [Abstract][Full Text] [Related]
3. Correlation between micronuclei frequency in peripheral blood lymphocytes and retention of 131-I in thyroid cancer patients.
Vrndić OB; Milošević-Djordjević OM; Mijatović Teodorović LC; Jeremić MZ; Stošić IM; Grujicić DV; Zivancević Simonović ST
Tohoku J Exp Med; 2013 Feb; 229(2):115-24. PubMed ID: 23337621
[TBL] [Abstract][Full Text] [Related]
4. Cytokinesis-block micronucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma.
Popova L; Hadjidekova V; Hadjieva T; Agova S; Vasilev I
Hell J Nucl Med; 2005; 8(1):54-7. PubMed ID: 15886755
[TBL] [Abstract][Full Text] [Related]
5. Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay.
Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Futatsuya R; Michigishi T; Tonami N; Seto H; Goodwin DA
J Nucl Med; 1998 Mar; 39(3):436-40. PubMed ID: 9529288
[TBL] [Abstract][Full Text] [Related]
6. The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with iodine-131.
Dardano A; Ballardin M; Caraccio N; Boni G; Traino C; Mariani G; Ferdeghini M; Barale R; Monzani F
Thyroid; 2012 Mar; 22(3):318-24. PubMed ID: 22181338
[TBL] [Abstract][Full Text] [Related]
7. Effect of in vivo exposure to iodine-131 on the frequency and persistence of micronuclei in human lymphocytes.
Livingston GK; Foster AE; Elson HR
J Toxicol Environ Health; 1993; 40(2-3):367-75. PubMed ID: 8230307
[TBL] [Abstract][Full Text] [Related]
8. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.
S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
[TBL] [Abstract][Full Text] [Related]
9. The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes.
Watanabe N; Kanegane H; Kinuya S; Shuke N; Yokoyama K; Kato H; Tomizawa G; Shimizu M; Funada H; Seto H
J Nucl Med; 2004 Apr; 45(4):608-11. PubMed ID: 15073256
[TBL] [Abstract][Full Text] [Related]
10. Measurement of micronuclei by cytokinesis-block method in human, cattle, goat, pig, rabbit, chicken and fish peripheral blood lymphocytes irradiated in vitro with gamma radiation.
Kim SR; Kim TH; Ryu SY; Lee HJ; Oh H; Jo SK; Oh KS; Park IC; Kim JC; Kang CM; Kim SH
In Vivo; 2003; 17(5):433-8. PubMed ID: 14598606
[TBL] [Abstract][Full Text] [Related]
11. Are thyroid cancer patients sensitive to ionising radiation?
García-Quispes WA; Pérez-Machado G; Sandoval B; Pastor S; Velázquez A; Galofré P; Biarnés J; Castell J; Marcos R
Int J Radiat Biol; 2011 Sep; 87(9):932-5. PubMed ID: 21605002
[TBL] [Abstract][Full Text] [Related]
12. Study of cytogenetic toxicity of low-dose radioiodine therapy in hyperthyroid patients using a micronuclei assay.
Parida GK; Bal C; Dada R; Tripathi M; Dwivedi S
Nucl Med Commun; 2016 Aug; 37(8):800-4. PubMed ID: 27081713
[TBL] [Abstract][Full Text] [Related]
13. Micronuclei frequency in peripheral blood lymphocytes of cancer patients: a meta-analysis.
Iarmarcovai G; Ceppi M; Botta A; Orsière T; Bonassi S
Mutat Res; 2008; 659(3):274-83. PubMed ID: 18582599
[TBL] [Abstract][Full Text] [Related]
14. Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131.
Ballardin M; Gemignani F; Bodei L; Mariani G; Ferdeghini M; Rossi AM; Migliore L; Barale R
Mutat Res; 2002 Feb; 514(1-2):77-85. PubMed ID: 11815246
[TBL] [Abstract][Full Text] [Related]
15. Micronuclei and 3AB-index in patients receiving iodine-131 therapy.
Catena C; Villani P; Nastasi R; Conti D; Righi E; Salerno G; Righi VA; Ronga G
J Nucl Biol Med (1991); 1994 Dec; 38(4):586-93. PubMed ID: 7786922
[TBL] [Abstract][Full Text] [Related]
16. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Luster M; Hänscheid H; Reiners C
J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
[No Abstract] [Full Text] [Related]
17. The effect of age, sex, and lifestyle factors on micronucleus frequency in peripheral blood lymphocytes of the Bosnian population.
Nefic H; Handzic I
Mutat Res; 2013 Apr; 753(1):1-11. PubMed ID: 23499242
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test.
Gutiérrez S; Carbonell E; Galofré P; Creus A; Marcos R
Eur J Nucl Med; 1999 Dec; 26(12):1589-96. PubMed ID: 10638411
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological effect of 99mTechnetium-MIBI in human peripheral blood lymphocytes: ex vivo study using micronucleus/FISH assay.
Taibi N; Aka P; Kirsch-Volders M; Bourgeois P; Frühling J; Szpireer C
Cancer Lett; 2006 Feb; 233(1):68-78. PubMed ID: 16473669
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and genome instability in children with autoimmune diseases.
Mihaljevic O; Zivancevic-Simonovic S; Milosevic-Djordjevic O; Djurdjevic P; Jovanovic D; Todorovic Z; Grujicic D; Radovic-Jakovljevic M; Tubic J; Markovic A; Paunovic M; Stanojevic-Pirkovic M; Markovic S
Mutagenesis; 2018 Dec; 33(5-6):351-357. PubMed ID: 30481337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
